Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 47 min ago
Peer-reviewedCC BY-NC-NDCell genomics

Establishing a genomic lab during COVID-19: A perspective from Institut Pasteur in Côte d'Ivoire.

  • Bérenger Aristide Ako Ako1
  • Stanislas Egomli Assohoun2
  • Bernadette Flore Tchepé Diplo3
  • Tata Gniré Safiatou Coulibaly4
  • Jean-René Quassi Acquah5
  • André Offianan Touré6
  • Hervé Albérique Adjé Kadjo7
  • Carole Valérie Gbonon8
  • Joseph Allico Djaman9
  • Mireille Dosso10
10 affiliations
  1. 1Malaria Research Unit, Department of Parasitology and Mycology, IPCI, Abidjan, Côte d'Ivoire; Metagenomics and Microbial Genomics Lab, Molecular Genetics Platform at IPCI, Abidjan, Côte d'Ivoire. Electronic address: [email protected].
  2. 2Malaria Research Unit, Department of Parasitology and Mycology, IPCI, Abidjan, Côte d'Ivoire; Metagenomics and Microbial Genomics Lab, Molecular Genetics Platform at IPCI, Abidjan, Côte d'Ivoire; Mechanics and Computer Sciences Lab, Félix Houphouët-Boigny University School of Mathematics and Computer Sciences, Abidjan, Côte d'Ivoire.
  3. 3Metagenomics and Microbial Genomics Lab, Molecular Genetics Platform at IPCI, Abidjan, Côte d'Ivoire; Cancer Genomics Lab, Molecular Genetics Platform, IPCI, Abidjan, Côte d'Ivoire.
  4. 4Cancer Genomics Lab, Molecular Genetics Platform, IPCI, Abidjan, Côte d'Ivoire.
  5. 5Metagenomics and Microbial Genomics Lab, Molecular Genetics Platform at IPCI, Abidjan, Côte d'Ivoire.
  6. 6Department of Parasitology and Mycology, IPCI, Abidjan, Côte d'Ivoire.
  7. 7National Reference Center for Respiratory Viruses, Department of Epidemic Viruses, IPCI, Abidjan, Côte d'Ivoire.
  8. 8Molecular Genetics Platform at IPCI, Abidjan, Côte d'Ivoire.
  9. 9Department of Fundamental and Clinical Biochemistry, IPCI, Abidjan, Côte d'Ivoire.
  10. 10Department of Bacteriology and Virology, IPCI, Abidjan, Côte d'Ivoire.
Read full textPDFDOICite

Abstract

Africa bears a disproportionate burden of epidemic threats, exemplified by COVID-19. Drawing on lessons from the pandemic, we describe how Institut Pasteur de Côte d'Ivoire transitioned from limited capacity to established expertise in genomic surveillance. This institutional strengthening provides a strategic blueprint for enhancing Africa's resilience against emerging health threats.

Related

  1. Immunogenicity and safety of Institut Pasteur du Cambodge (IPC) and updated Thai Red Cross (UTRC) intradermal rabies vaccine regimens among healthy adults in India: A phase 4, open label, equivalence randomised controlled trial
    Jeromie Wesley Vivian Thangaraj, Padinjaremattathil Thankappan Ullas, Balaji Dagadu More +25
    PLOS MedicinePeer-reviewedCC BY 4.0Full textGeneral biochemistryImmunologyPLOSPMC
  2. Genomic Epidemiology of CHIKV During the Largest Outbreak in Mainland China-Implication for CHIKV Intervention
    L. Yi, s. xiang, X. Huang +10
    medRxivPreprintAll rights reservedFull textEpidemiology & public healthmedRxiv
  3. SARS-CoV-2 infection and genomic diversity in Quilombola communities during Brazil’s gamma VOC wave
    Filipe Ferreira de Almeida Rego, Luciane Amorim Santos, Marina Silveira Cucco +12
    iSciencePeer-reviewedCC BY 4.0Epidemiology & public healthCell PressCrossref
  4. Genomic epidemiology of measles viruses circulating during the 2026 nationwide measles outbreak in Bangladesh
    Md. Abdullah Omar Nasif, Sharmin Sultana, Mahbubur Rahman +10
    International Journal of Infectious DiseasesPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
  5. Theodicy perspective as an effect of the interpenetration of mental and religious issues during the COVID-19 pandemic in Poland
    Grzegorz Adamczyk, Arkadiusz Jabłoński, Piotr T. Nowakowski +1
    PLOS OnePeer-reviewedCC BY 4.0Full textEpidemiology & public healthInfectious diseasePLOS

Cite

BibTeXRIS
BibTeX
@article{ako2026establishing,
  title = {{Establishing a genomic lab during COVID-19: A perspective from Institut Pasteur in Côte d'Ivoire.}},
  author = {Bérenger Aristide Ako Ako and Stanislas Egomli Assohoun and Bernadette Flore Tchepé Diplo and Tata Gniré Safiatou Coulibaly and Jean-René Quassi Acquah and André Offianan Touré and Hervé Albérique Adjé Kadjo and Carole Valérie Gbonon and Joseph Allico Djaman and Mireille Dosso},
  journal = {Cell genomics},
  year = {2026},
  month = oct,
  doi = {10.1016/j.xgen.2026.101385},
  url = {https://europepmc.org/article/MED/42874563},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Establishing a genomic lab during COVID-19: A perspective from Institut Pasteur in Côte d'Ivoire.
AU  - Bérenger Aristide Ako Ako
AU  - Stanislas Egomli Assohoun
AU  - Bernadette Flore Tchepé Diplo
AU  - Tata Gniré Safiatou Coulibaly
AU  - Jean-René Quassi Acquah
AU  - André Offianan Touré
AU  - Hervé Albérique Adjé Kadjo
AU  - Carole Valérie Gbonon
AU  - Joseph Allico Djaman
AU  - Mireille Dosso
PY  - 2026
DA  - 2026/10/01
JO  - Cell genomics
DO  - 10.1016/j.xgen.2026.101385
UR  - https://europepmc.org/article/MED/42874563
AB  - Africa bears a disproportionate burden of epidemic threats, exemplified by COVID-19. Drawing on lessons from the pandemic, we describe how Institut Pasteur de Côte d'Ivoire transitioned from limited capacity to established expertise in genomic surveillance. This institutional strengthening provides a strategic blueprint for enhancing Africa's resilience against emerging health threats.
SN  - 2666-979X
ER  -